Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
| ▸ | BAD | Q92934 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 3/20 | 0.34 |
| ▸ | DRD3 | P35462 | 2/20 | 0.34 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | EGFR | P00533 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | FYN | P06241 | 2/20 | 0.33 |
| ▸ | MMP9 | P14780 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27486701 | 0.83 | ALDH1A1 (0.35) | BCL2L1BADDRD2DRD3PARP1 | |
| SCHEMBL276579 | 0.78 | BCL2L1 (0.39) | BCL2L1BADDRD2DRD3PARP1 | |
| SCHEMBL28149914 | 0.78 | BCL2L1 (0.43) | BCL2L1BADDRD2DRD3PARP1 | |
| SCHEMBL27664477 | 0.77 | BCL2L1 (0.38) | BCL2L1BADDRD2DRD3PARP1 | |
| SCHEMBL14714269 | 0.75 | — | — | |
| SCHEMBL31170847 | 0.75 | PARP10 (0.34) | — | |
| SCHEMBL31170737 | 0.75 | ADRA2A (0.36) | LMNA | |
| SCHEMBL19692682 | 0.75 | PARP1 (0.34) | PARP1ALDH1A1CA2CA1 | |
| SCHEMBL12320946 | 0.75 | — | — | |
| SCHEMBL7650577 | 0.75 | CD44 (0.36) | PARP1ALDH1A1LMNAHPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220340539-A1 | COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF | GENEORA PHARMA (SHIJIAZHUANG) CO., LTD. (CN) | 2022-10-27 | — | — | US | claimed |
| EP-4039678-A1 | COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shandong Luye Pharmaceutical Co., Ltd. (CN) | 2022-08-10 | — | — | EP | claimed |
| CN-114423746-A | Compound and preparation method and application thereof | 山东绿叶制药有限公司 | 2022-04-29 | — | — | CN | claimed |
| WO-2021063347-A1 | COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF | 山东绿叶制药有限公司 | 2021-04-08 | — | — | WO | claimed |
| WO-2013083582-A1 | ANTIMICROBIAL COMPOSITION | UNILEVER N.V. (NL) | 2013-06-13 | — | — | WO | claimed |
| EP-4649941-A1 | METHOD FOR PREPARING STERILE IN-SITU GEL ON BASIS OF SOLVENT REMOVAL TECHNIQUE AND PRODUCT THEREOF | Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. (CN) | 2025-11-19 | — | — | EP | disclosed |
| EP-4628076-A1 | ROTIGOTINE-CONTAINING PATCH AND METHOD FOR IMPROVING STABILITY OF ROTIGOTINE | Hisamitsu Pharmaceutical Co., Inc. (JP) | 2025-10-08 | — | — | EP | disclosed |
| US-20250161265-A1 | ROTIGOTINE-CONTAINING ADHESIVE PATCH | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 2025-05-22 | — | — | US | disclosed |
| EP-4483873-A1 | ROTIGOTINE-CONTAINING ADHESIVE PATCH | Hisamitsu Pharmaceutical Co., Inc. (JP) | 2025-01-01 | — | — | EP | disclosed |
| US-20240415765-A1 | CONTINUOUS DELIVERY PREPARATION CAPABLE OF BEING STABLY RELEASED AND PREPARATION METHOD THEREFOR | SICHUAN KELUN PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD. (CN) | 2024-12-19 | — | — | US | disclosed |
| EP-4454636-A1 | CONTINUOUS DELIVERY PREPARATION CAPABLE OF BEING STABLY RELEASED AND PREPARATION METHOD THEREFOR | Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. (CN) | 2024-10-30 | — | — | EP | disclosed |
| CN-118843462-A | Rotigotine-containing patch | 久光制药株式会社 | 2024-10-25 | — | — | CN | disclosed |
| CN-1402633-A | Transdermal therapeutic system with improved stability and method for the production thereof | LOHMANN THERAPIE SYST LTS (DE) | 2003-03-12 | — | — | CN | disclosed |
| WO-2003015715-A2 | TETRAHYDROQUINOLINE DERIVATIVES AS ANTITHROMBOTIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-02-27 | — | — | WO | disclosed |
| EP-0157436-B1 | PERFUME COMPOSITIONS AND PERFUMED ARTICLES CONTAINING DIHYDRO- AND/OR TETRAHYDRO-NAPHTOLS AS FRAGRANCE MATERIAL | NAARDEN INTERNATIONAL N.V. (NL) | 1990-01-03 | — | — | EP | disclosed |
| US-4643844-A | LEATHER ODOR | 501 Naarden International N.V. (NL) | 1987-02-17 | — | — | US | disclosed |
| EP-0157436-A1 | Perfume compositions and perfumed articles containing dihydro- and/or tetrahydro-naphtols as fragrance material | NAARDEN INTERNATIONAL N.V. (NL) | 1985-10-09 | — | — | EP | disclosed |
| US-4435397-A | ADRENERGIC BLOCKING AGENTS, 4-(3-ARYLOXY-2-HYDROXYPROPYL) SUBSTITUTED | NIPPON SHINYAKU CO., LTD. (JP) | 1984-03-06 | — | — | US | disclosed |
| US-4265911-A | Propionamidoxime derivatives | SYNTHELABO (FR) | 1981-05-05 | — | — | US | disclosed |
| US-3943149-A | HYPOCHOLESTEREMIC, ANTIINFLAMMATORY | E. R. SQUIBB & SONS, INC. (US) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220340539-A1 | COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF | FURIN, VIP, SORD | BCL2L1 4263/4885BAD 1736/4885DRD2 2311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.